Macrogenics (MGNX) Other Non-Current Assets (2012 - 2026)
Macrogenics' (MGNX) quarterly Other Non-Current Assets came in at $1.4 million in Q1 2026, down 7.65% year-on-year from $1.5 million in Q1 2025, and down 0.65% on a QoQ basis from $1.4 million in Q4 2025.
Macrogenics (MGNX) Other Non-Current Assets (2012 - 2026) Analysis & Trends
Macrogenics (MGNX) has 15 years of Other Non-Current Assets data on file, last reported at $1.4 million in Q1 2026.
- On a quarterly basis, Other Non-Current Assets fell 7.65% year-over-year to $1.4 million in Q1 2026; TTM through Mar 2026 was $1.4 million, a 7.65% decrease from a year earlier, with the FY2025 full-year figure at $1.4 million, down 10.99% from the prior year.
- Other Non-Current Assets for Q1 2026 stood at $1.4 million, down from $1.4 million in the prior quarter.
- Over the last five years, Other Non-Current Assets for MGNX reached as high as $17.2 million in Q1 2022 and fell as low as $1.2 million in Q1 2024.
- Historically, Other Non-Current Assets has averaged $4.0 million across 5 years, with a median of $1.4 million in 2023.
- Across the five-year window, Other Non-Current Assets plunged 91.99% in 2023 and rose 25.74% in 2025, its largest moves.
- Year by year, Other Non-Current Assets stood at $1.4 million in 2022, then gained by 0.58% to $1.4 million in 2023, then rose by 12.27% to $1.6 million in 2024, then dropped by 10.99% to $1.4 million in 2025, then decreased by 0.65% to $1.4 million in 2026.
- Per Business Quant data, the three most recent Other Non-Current Assets figures were $1.4 million in Q1 2026, $1.4 million in Q4 2025, and $1.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | Macrogenics | 254.43 Mn | 187.92 Mn | - | 1.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.38 Mn |
| Dec 31, 2025 | 1.39 Mn |
| Sep 30, 2025 | 1.39 Mn |
| Jun 30, 2025 | 1.40 Mn |
| Mar 31, 2025 | 1.49 Mn |
| Dec 31, 2024 | 1.56 Mn |
| Sep 30, 2024 | 1.19 Mn |
| Jun 30, 2024 | 1.19 Mn |
| Mar 31, 2024 | 1.19 Mn |
| Dec 31, 2023 | 1.39 Mn |
| Sep 30, 2023 | 1.39 Mn |
| Jun 30, 2023 | 1.39 Mn |
| Mar 31, 2023 | 1.38 Mn |
| Dec 31, 2022 | 1.38 Mn |
| Sep 30, 2022 | 15.54 Mn |
| Jun 30, 2022 | 16.39 Mn |
| Mar 31, 2022 | 17.21 Mn |
| Dec 31, 2021 | 1.40 Mn |
| Sep 30, 2021 | 18.78 Mn |
| Jun 30, 2021 | 19.52 Mn |